title: Elevated pro-brain natriuretic peptide, troponin T and malnutrition inflammatory score in chronic hemodialysis patients with overt cardiovascular disease.
abstract: BACKGROUND
  We assessed the relationship between pro-brain natriuretic peptide (pro-BNP), troponin T (TropT) and nutritional status.
  
  
  METHODS
  A total of 48 chronic hemodialysis patients were grouped according to the presence [group A (GA); n = 24] or not [group B (GB)] of cardiovascular disease.
  
  
  RESULTS
  Compared to GB subjects, GA subjects were older, had been on hemodialysis for a longer period and had higher prevalences of vascular grafts, hypertension and elevated C-reactive protein (CRP) [GA vs. GB: 1.1 (range 0.1-32.9) vs. 0.4 (0-28.1) mg/dl; p = 0.028], malnutrition inflammatory score (MIS) (GA vs. GB: 7.50 vs. 4.00; p = 0.001), pro-BNP [GA vs. GB: 6,760 (601-103,200) vs. 686 (75-83,700) pg/ml; p < 0.001] and TropT [GA vs. GB: 0.3650 (0.011-0.199) vs. 0.010 (0.0-0.290) ng/ml; p = 0.002]. Pro-BNP correlated with TropT (rho 0.539; p < 0.001), MIS (rho 0.502; p < 0.0001), homocysteine (rho 0.321; p = 0.13) and CRP (rho 0.511; p < 0.0001). Pro-BNP levels were lower in GB patients as the body mass index increased; the opposite occurred in GA.
  
  
  CONCLUSIONS
  Patients with cardiovascular disease had elevated pro-BNP and TropT levels. In patients without cardiovascular disease, malnutrition and inflammation were associated with vascular prostheses, while pro-BNP was lower in obese patients.
authors.affiliation: Servicio de Nefrología, Hospital Británico de Buenos Aires, Buenos Aires, Argentina. htrimarchi@hotmail.com
authors.forename: Hernán
authors.initials: H
authors.lastname: Trimarchi
authors.forename: Alexis
authors.initials: A
authors.lastname: Muryan
authors.forename: Vicente
authors.initials: V
authors.lastname: Campolo-Girard
authors.forename: Mariana
authors.initials: M
authors.lastname: Dicugno
authors.forename: Nanci
authors.initials: N
authors.lastname: Barucca
authors.forename: Fernando
authors.initials: F
authors.lastname: Lombi
authors.forename: Pablo
authors.initials: P
authors.lastname: Young
authors.forename: Vanesa
authors.initials: V
authors.lastname: Pomeranz
authors.forename: Mariano
authors.initials: M
authors.lastname: Forrester
authors.forename: Mirta
authors.initials: M
authors.lastname: Alonso
authors.forename: Romina
authors.initials: R
authors.lastname: Iriarte
authors.forename: Marisa Luisa
authors.initials: ML
authors.lastname: Díaz
authors.forename: Bengt
authors.initials: B
authors.lastname: Lindholm
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D002318:Cardiovascular Diseases / Q000097:blood* / Q000628:therapy; D015331:Cohort Studies; D005260:Female; D006801:Humans; D018836:Inflammation Mediators / Q000009:adverse effects / Q000097:blood*; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000628:therapy*; D008297:Male; D044342:Malnutrition / Q000097:blood*; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood*; D011446:Prospective Studies; D006435:Renal Dialysis / Q000009:adverse effects; D020107:Troponin T / Q000097:blood*
chemical_list: D015415:Biomarkers; D018836:Inflammation Mediators; D010446:Peptide Fragments; D020107:Troponin T; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain